Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Considerations for the Assessm...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation

Bibliographic Details
Main Authors: Dominik Linz, Sander Verheule, Aaron Isaacs, Ulrich Schotten
Format: Article
Language:English
Published: Radcliffe Medical Media 2021-10-01
Series:Arrhythmia & Electrophysiology Review
Online Access:https://www.aerjournal.com/articleindex/aer.2020.51
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.aerjournal.com/articleindex/aer.2020.51

Similar Items

  • ATRIAL SOURCES OF REACTIVE OXYGEN SPECIES VARY WITH THE SUBSTRATE AND DURATION OF ATRIAL FIBRILLATION: IMPLICATIONS FOR THE ANTIARRHYTHMIC EFFECT OF STATINS
    by: Reilly, S, et al.
    Published: (2011)
  • Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins
    by: Reilly, S, et al.
    Published: (2011)
  • Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.
    by: Reilly, S, et al.
    Published: (2011)
  • Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.
    by: Reilly, SN, et al.
    Published: (2011)
  • Central sleep apnea in atrial fibrillation: Risk factor or marker of untreated underlying disease?
    by: Dominik Linz, et al.
    Published: (2020-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs